Gunjan Sharma

About

I am a researcher in the field of Biomedical Sciences with more than 12 years of post-PhD experience in varied fields such as Cancer, Immunotherapy, Glycobiology, Genetics, Molecular Biology, Animal Experimentation, Biochemistry etc. I have amassed experience both in academia and industry after my PhD.

Employment

• Nizam's Institute of Medical Sciences Scientist C
  2021 - Present
• L V Prasad Eye Institute Post-doctoral associate III
  2020 - 2021
• Dr. Reddy's Laboratories (India) Senior Scientist (Team Lead)
  2016 - 2019
• Lund University Post-Doctoral Researcher
  2013 - 2015

Education

• CSIR – Indian Institute of Chemical Biology PhD (Biochemistry)
  2007 - 2012
• Banaras Hindu University Faculty of Science MSc (Biotech)
  2005 - 2007
• Banaras Hindu University Faculty of Science BSc (Chemistry Hons)
  2001 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Investigation of Association of TYK2-P1104A Variant in Systemic Lupus Erythematosus Patients With or Without Tuberculosis
  Indian Journal of Clinical Biochemistry 2024 DOI: 10.1007/s12291-024-01276-y
  +Save
• Antigen-Specific Intraocular Cytokine Responses Distinguish Ocular Tuberculosis From Undifferentiated Uveitis in Tuberculosis-Immunoreactive Patients
  American Journal of Ophthalmology 2023 DOI: 10.1016/J.AJO.2022.08.029
  +Save
• Hypermethylation and reduced expression of lipoprotein metabolism genes ABCG1, LIPC and PLTP in Obese and Diabetic subjects: Potential risk factors for Coronary artery disease
  Indian Journal of Experimental Biology 2023 DOI: 10.56042/IJEB.V61I07.2212
  +Save
• Mixed B- and T-lymphocyte Vitreous Infiltrate in Multiple Sclerosis Associated Uveitis.
  Ocular immunology and inflammation 2022 DOI: 10.1080/09273948.2022.2079536
  +Save
• Extracellular and intracellular small-molecule galectin-3 inhibitors.
  Scientific reports 2019 DOI: 10.1038/s41598-019-38497-8
  +Save
• Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition.
  Chembiochem : a European journal of chemical biology 2016 DOI: 10.1002/cbic.201600285
  +Save
• Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway.
  Journal of cellular physiology 2015 DOI: 10.1002/jcp.24818
  +Save
• The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms.
  Cellular & molecular immunology 2014 DOI: 10.1038/cmi.2013.68
  +Save
• Novel and facile fluorescene microscopy method for detection of intracellular galectin-3 inhibition by small molecules in vitro
  Molecular Biology of the Cell 2014
  +Save
• Treatment of pancreatic cancer cell lines with high-affinity galectin-3 inhibitor further confirms novel intracellular function of galectin-3 and implications in anticancer therapy
  Molecular Biology of the Cell 2014
  +Save